New Enterprise Associates (NEA) is a prominent venture capital firm established in 1977, headquartered in Menlo Park, California, with additional offices in the U.S., India, and China. NEA specializes in investing in technology and healthcare sectors, with a focus on enterprise, consumer, fintech, life sciences, and digital health companies. The firm engages with entrepreneurs at various stages of business development, providing support from initial funding to public offerings. NEA invests globally, with a significant presence in Asia, including China and India, as well as the United States. The firm typically invests between $0.05 million and $20 million per deal.
Glacier, founded in 2019 and based in San Francisco, California, has developed the first affordable, high-performing, and space-efficient AI-enabled robot designed specifically for recycling. The company aims to transform the recycling industry by utilizing artificial intelligence-powered sensors and robotics to automate the sorting of recyclable materials. This innovative approach allows recycling facilities to enhance their operational efficiency, improve sorting accuracy, and ultimately increase profitability. By integrating advanced technology into the recycling process, Glacier is positioned to significantly impact how recycling facilities manage and process materials.
Plaid
Venture Round in 2025
Plaid Inc. is a technology company that facilitates the connection between consumers' bank accounts and applications, aiming to democratize financial services through advanced technological solutions. Founded in 2012 and headquartered in San Francisco, it provides a comprehensive suite of APIs that enable developers to create financial products connecting users with traditional financial institutions. Plaid's offerings include tools for accessing transaction history and balance data, authenticating bank accounts for payments, verifying identities, and confirming real-time account balances and income. These products support various applications in personal finances, consumer payments, lending, banking, and business finance. With a focus on enhancing both consumer experiences and developer capabilities, Plaid serves a diverse range of clients, including Fortune 50 companies, positioning itself as a vital infrastructure provider in the digital financial landscape.
Vori Health
Series B in 2025
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
Abcuro
Series C in 2025
Abcuro, Inc. is a biotechnology company focused on developing immunotherapies for the treatment of autoimmunity and cancer. Based in Newton, Massachusetts, Abcuro creates therapeutic antibodies targeting novel mechanisms related to these diseases. The company utilizes advanced bioinformatics to analyze transcription data from human diseases, which aids in the identification of new therapeutic targets. Through ex-vivo validation in diseased tissues, Abcuro seeks to uncover innovative methods to modulate key components of the immune system. Established in 2015, Abcuro aims to enhance treatment strategies in the healthcare industry by offering effective solutions for complex immunological conditions.
Instabase
Series D in 2025
Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.
Outrider
Series D in 2024
Outrider, Inc. is a software company that specializes in automating logistics hubs through the use of electric, self-driving trucks. Established in 2017 and based in Golden, Colorado, Outrider provides a software-as-a-service (SaaS) solution designed for customer-owned freight and transportation fleets. The company offers a comprehensive system comprised of web-based management software, autonomous driving controls for electric yard trucks, and necessary site infrastructure. Its technology automates various yard operations, including the movement of trailers and the engagement and disengagement of trailer connections, thereby eliminating hazardous and repetitive manual tasks. By focusing on the development of zero-emission systems, Outrider aims to enhance safety and efficiency for large enterprises reliant on logistics.
Second Front
Series C in 2024
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.
PayZen
Series B in 2024
PayZen is a healthcare fintech startup founded in 2019 in San Francisco by Ariel Rosenthal, Itzik Cohen, and Tobias Mezger. The company addresses the challenge of patient payment responsibilities by providing a platform that allows patients to pay their out-of-pocket medical bills over time, enhancing convenience and transparency. PayZen's technology utilizes artificial intelligence to create tailored payment plans that cater to individual financial situations, thereby improving affordability for patients. This approach not only facilitates timely payments but also helps medical providers optimize cash flow and minimize the costs associated with collecting outstanding invoices. By focusing on patient financing solutions, PayZen enables healthcare providers to concentrate on delivering medical care rather than managing financial transactions.
Moximed
Series D in 2024
Moximed, Inc. is a medical technology company based in Hayward, California, focused on developing innovative solutions for patients with knee osteoarthritis. The company offers the Atlas System, an implantable joint unloader designed to alleviate pain for individuals suffering from medial compartment knee osteoarthritis. This system operates similarly to a shock absorber, providing dynamic load reduction to minimize joint pain and enhance mobility. Moximed also features the MISHA Knee System, which offers an outpatient treatment option for patients who have not found relief through other therapies and are not suitable candidates for knee replacement surgery. By addressing the specific needs of osteoarthritis patients, Moximed aims to improve their quality of life while potentially delaying the need for more invasive surgical interventions. Founded in 2006, the company serves patients and medical professionals worldwide.
MBX Biosciences
Series C in 2024
MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.
Cardurion Pharmaceuticals
Series B in 2024
Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.
Zenas BioPharma
Series C in 2024
Zenas BioPharma is a clinical-stage biopharmaceutical company based in Florida, dedicated to developing immune-based therapies for patients. The company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody that targets both CD19 and FcγRIIb, which are found on B cells. This innovative approach aims to inhibit the activity of B cells involved in various autoimmune diseases while preserving their overall population, thus offering a potential therapeutic advantage over traditional treatments that deplete these cells.
SafeBase
Series B in 2024
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.
Xaira Therapeutics
Venture Round in 2024
Xaira Therapeutics is an integrated biotechnology company focused on revolutionizing drug discovery and development through the application of artificial intelligence. Headquartered in the San Francisco Bay Area, Xaira combines expertise in machine learning, extensive biological and clinical data generation, and robust therapeutic product development. By harnessing advanced AI techniques, the company aims to enhance the understanding of biological processes and improve the effectiveness of therapies. Xaira's approach encompasses all stages of drug discovery, striving to transform how diseases are treated and enabling clients to deliver innovative therapeutic solutions.
Korro Bio
Post in 2024
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.
Lily AI
Series B in 2024
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.
Regulus Therapeutics
Post in 2024
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company based in San Diego, California, specializing in the discovery and development of therapies that target microRNAs for various diseases. The company is advancing its lead product candidates, RG-012 and RGLS4326, which are in Phase II and Phase Ib clinical trials, respectively. RG-012 targets miR-21 for the treatment of Alport syndrome, a severe kidney disease, while RGLS4326 targets miR-17 for autosomal dominant polycystic kidney disease. In addition to these candidates, Regulus is developing a pipeline of preclinical drug products, including RGLS5579, aimed at inhibiting miR-10b, as well as programs targeting hepatitis B virus and non-alcoholic steatohepatitis. Founded in 2007, Regulus Therapeutics is at the forefront of leveraging the therapeutic potential of microRNA, a significant scientific breakthrough in recent years.
Glacier
Venture Round in 2024
Glacier, founded in 2019 and based in San Francisco, California, has developed the first affordable, high-performing, and space-efficient AI-enabled robot designed specifically for recycling. The company aims to transform the recycling industry by utilizing artificial intelligence-powered sensors and robotics to automate the sorting of recyclable materials. This innovative approach allows recycling facilities to enhance their operational efficiency, improve sorting accuracy, and ultimately increase profitability. By integrating advanced technology into the recycling process, Glacier is positioned to significantly impact how recycling facilities manage and process materials.
Second Front
Venture Round in 2024
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.
VAST Data
Series E in 2023
VAST Data, Inc. specializes in developing innovative data storage solutions, offering a universal storage platform that integrates Intel’s Optane SSDs as a cache for data stored on quad-level cell (QLC) SSDs. Founded in 2016 and headquartered in New York, with an additional office in San Jose, VAST Data serves various industries, including animation, visual effects, deep learning, and enterprise backup recovery. The platform is designed to accelerate time-to-insight for workload-intensive applications, providing scalable performance, simple data management, and improved productivity for AI-driven organizations. Since its launch in 2019, VAST Data has gained recognition as a rapidly growing player in the data infrastructure sector.
Second Front
Series B in 2023
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.
Transfix
Series F in 2023
Transfix, Inc. is a trucking brokerage firm based in New York that specializes in connecting shippers with carriers for freight transportation across the United States. Founded in 2010, the company has developed an online freight management platform that utilizes advanced algorithms and business intelligence to enhance supply chain visibility and efficiency. Transfix offers services such as real-time shipment tracking, carrier performance insights, and support tailored to various industries, including retail, food, beverage, and manufacturing. By leveraging its Intelligent Freight Platform, Transfix aims to optimize logistics processes, reduce empty miles, and improve overall supply chain performance for its clients.
Mojo Vision
Series A in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Pair Eyewear
Series C in 2023
Pair Eyewear, founded in 2017 and based in New York, specializes in customizable eyeglasses for children. The company offers a unique product line that includes base frames, which are standard glasses, and top frames, which are snap-on fronts that can be easily changed to reflect a child's evolving interests and personalities. By leveraging an e-commerce platform, Pair Eyewear aims to transform the eyeglass experience into an engaging activity for children while simplifying the process for parents. The brand focuses on quality and affordability, providing eyewear that combines style with functionality, featuring hand-polished acetate frames and shatterproof polycarbonate lenses.
Pulumi
Series C in 2023
Pulumi Corporation operates an infrastructure-as-a-code platform that facilitates the development, deployment, and management of cloud applications and infrastructure. Founded in 2017 and based in Seattle, Washington, Pulumi offers the Pulumi SDK, an open-source tool that enables developers and DevOps teams to utilize programming languages for defining and managing cloud services across various environments, including public, private, and hybrid clouds. The platform supports a range of application types, from serverless functions to containerized applications, and emphasizes collaboration among teams to streamline cloud engineering processes. By providing a consistent workflow for delivering and securing applications, Pulumi helps businesses effectively create modern applications and manage their cloud environments.
Gossamer Bio
Post in 2023
Gossamer Bio is a clinical-stage biopharmaceutical company based in San Diego that specializes in the discovery, development, and commercialization of innovative therapeutic products targeting significant unmet medical needs. Founded by former executives from Receptos, the company focuses on areas such as immunology, inflammation, fibrosis, and oncology. Its pipeline includes several promising candidates: Seralutinib, aimed at addressing pulmonary arterial hypertension; GB004, for inflammatory bowel disease; GB1275, targeting various oncology indications; and GB001, designed for moderate-to-severe eosinophilic asthma. Gossamer Bio's strategy involves leveraging a rich in-licensing environment to enhance its therapeutic offerings, supported by a team recognized for their successful track record in drug development.
Instabase
Series C in 2023
Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.
Strive Health
Series C in 2023
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.
Sundeck
Seed Round in 2023
Sundeck is a data infrastructure and analytics company based in Santa Clara, California, founded by Jacques Nadeau in 2022. The company specializes in customizing the behavior of Snowflake queries to enhance their functionality. Sundeck's platform allows for warehouse optimization, adaptive routing, and granular cost control, empowering data engineers to address complex challenges in query management. By executing pre- and post-hook SQL across various business intelligence and AI tools, Sundeck enhances user creativity while providing robust control over data operations.
Regulus Therapeutics
Post in 2023
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company based in San Diego, California, specializing in the discovery and development of therapies that target microRNAs for various diseases. The company is advancing its lead product candidates, RG-012 and RGLS4326, which are in Phase II and Phase Ib clinical trials, respectively. RG-012 targets miR-21 for the treatment of Alport syndrome, a severe kidney disease, while RGLS4326 targets miR-17 for autosomal dominant polycystic kidney disease. In addition to these candidates, Regulus is developing a pipeline of preclinical drug products, including RGLS5579, aimed at inhibiting miR-10b, as well as programs targeting hepatitis B virus and non-alcoholic steatohepatitis. Founded in 2007, Regulus Therapeutics is at the forefront of leveraging the therapeutic potential of microRNA, a significant scientific breakthrough in recent years.
SimpleRose
Venture Round in 2023
SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making processes in complex environments. Founded in 2018, the company's solutions focus on optimizing operations through applications such as scheduling, production planning, and portfolio optimization. By leveraging algorithmic innovations for improved numerical accuracy and speed, SimpleRose enables organizations to tackle intricate operational challenges and make informed decisions in real-time.
Mojo Vision
Series C in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Relievant Medsystems
Venture Round in 2023
Relievant Medsystems, Inc. is a medical device company focused on developing minimally invasive treatments for chronic axial low back pain. The company has created the Intracept procedure, which specifically targets the basivertebral nerve to alleviate chronic vertebrogenic low back pain. By delivering targeted energy into the spine, the Intracept System effectively blocks the transmission of pain signals, providing patients with a low-risk therapeutic option. Founded in 2004, Relievant is headquartered in Minneapolis, Minnesota, with additional operations in Sunnyvale, California.
OP3N
Series A in 2023
Founded in 2021 as a subsidiary of EST Media Holdings, OP3N is a global Web3 superapp that integrates communication, connection, and commerce within a unified interface, facilitating on-chain interactions. The company aims to foster a more decentralized and democratized creator economy by consolidating essential tools for minting, sharing, and engaging with digital goods and tokens. OP3N's leadership team, which includes media executive Jaeson Ma and development executive Eric Tu, brings extensive experience from the entertainment, gaming, and technology sectors. The company is committed to creating community-driven entertainment experiences and has established partnerships for various projects, including collaborations with Tokyo fashion label AMBUSH, an intergalactic children's book by Grimes, and a musical film with Simon Fuller. OP3N is headquartered in Los Angeles and focuses on empowering artists to directly engage with their fans through token-gated access, all within a Web3 framework.
Fabric8Labs
Series B in 2023
Fabric8Labs, Inc., founded in 2015 and based in La Jolla, California, specializes in non-thermal metal 3D printing technology. The company has developed a distinctive process that combines stereo-lithography and electro-deposition, providing an innovative alternative to traditional powder bed fusion methods. This technology eliminates the need for metal powders, vacuum chambers, and lasers, which significantly reduces manufacturing costs. Moreover, Fabric8Labs' approach enhances material quality and simplifies the additive manufacturing process by utilizing cartridges that ensure safety during production and facilitate easy disposal of used salt cartridges. Through these advancements, Fabric8Labs aims to revolutionize the landscape of metal 3D printing.
Crowdbotics
Series B in 2023
Crowdbotics Corporation is a software development company that provides an application builder platform aimed at streamlining the creation and deployment of web and mobile applications. Founded in 2016 and based in Richmond, California, Crowdbotics enables product managers and developers to transform ideas into functional code by utilizing a comprehensive library of millions of production-grade software components. The platform employs systematic code reuse and artificial intelligence to match specific application requirements with existing code modules, enhancing efficiency and reducing risk. Additionally, Crowdbotics offers ongoing support services, including infrastructure management, implementation, maintenance, monitoring, and security for applications throughout their lifecycle, which allows businesses to focus on achieving their objectives while minimizing development time.
Outrider
Series C in 2023
Outrider, Inc. is a software company that specializes in automating logistics hubs through the use of electric, self-driving trucks. Established in 2017 and based in Golden, Colorado, Outrider provides a software-as-a-service (SaaS) solution designed for customer-owned freight and transportation fleets. The company offers a comprehensive system comprised of web-based management software, autonomous driving controls for electric yard trucks, and necessary site infrastructure. Its technology automates various yard operations, including the movement of trailers and the engagement and disengagement of trailer connections, thereby eliminating hazardous and repetitive manual tasks. By focusing on the development of zero-emission systems, Outrider aims to enhance safety and efficiency for large enterprises reliant on logistics.
SetPoint Medical
Venture Round in 2023
SetPoint Medical is a clinical-stage bioelectronic medicine company based in Valencia, California, focused on developing implantable neuromodulation devices aimed at treating chronic autoimmune diseases. The company is creating a platform that stimulates the vagus nerve to activate the body's natural inflammatory reflex, leading to a systemic immune-restorative effect. This innovative approach offers an alternative treatment option for conditions such as rheumatoid arthritis and inflammatory bowel disease, with the potential for reduced risks and costs compared to traditional drug therapies. SetPoint Medical, originally known as Innovative Metabolics Inc. until its name change in 2008, aims to provide patients and healthcare providers with effective solutions for managing debilitating inflammatory diseases.
Minerva Surgical
Post in 2022
Minerva Surgical Inc. is a medical technology company based in Redwood City, California, dedicated to women's healthcare. Founded in 2008, the company specializes in developing, manufacturing, and commercializing minimally invasive solutions for uterine health. Its flagship product, the Minerva Endometrial Ablation System, is designed to treat abnormal uterine bleeding, a common issue affecting many women. Minerva Surgical offers a comprehensive range of alternatives to hysterectomy, aiming to address the underlying causes of abnormal uterine bleeding while preserving the uterus. These solutions are applicable in various medical environments and seek to overcome the limitations of traditional treatment methods, providing women with effective and less invasive options for their healthcare needs.
Gladly
Venture Round in 2022
Gladly Software, Inc. is a San Francisco-based company that specializes in cloud-based software designed for the contact center market, primarily serving B2C brands. Founded in 2014, Gladly provides a customer service platform that facilitates seamless communication between brands and their customers across various channels, including voice, email, messaging, chat, and social media. The platform focuses on fostering meaningful interactions, allowing agents to engage with customers in a way that prioritizes personal connection and builds long-term loyalty. By centering the customer experience, Gladly aims to enhance agent empowerment and create consistently positive experiences that resonate with users. The company is supported by notable investors, including Greylock Partners, GGV Capital, NEA, and JetBlue Ventures.
Escient Pharmaceuticals
Series C in 2022
Escient Pharmaceuticals is a biotechnology company based in San Diego, California, that develops and manufactures drugs targeting G protein-coupled receptors (GPCRs) for the treatment of neuro-immuno-inflammatory and autoreactive diseases. Founded in 2017, the company specializes in harnessing the therapeutic potential of specific orphan GPCRs, particularly the Mas-Related G-Protein Receptors (Mrgprs), to address various neurosensory-inflammatory disorders. Escient's innovative approach aims to provide first-in-class therapies for conditions associated with mast cell-mediated disorders and cholestatic pruritus, thereby expanding treatment options for healthcare providers and patients facing these challenging diseases.
Dandelion Energy
Series B in 2022
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.
MBX Biosciences
Series B in 2022
MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.
Merge
Series B in 2022
Merge provides a comprehensive platform for B2B companies to streamline their integration processes through a single application programming interface (API). Founded in 2020, the company specializes in offering Unified APIs that facilitate secure data access across various software categories, such as human resources, accounting, customer relationship management, and file storage. Merge manages the complete integration lifecycle, from a swift initial setup to ongoing maintenance and observability tools, ensuring customer satisfaction. Its services help businesses enhance their operational efficiency by reducing customer churn, accelerating product development, and lowering engineering costs. Based in San Francisco, New York City, and Berlin, Merge has garnered significant support, receiving $75 million in funding from notable investors.
Swift Navigation
Series D in 2022
Swift Navigation, Inc. is a technology company specializing in precise global positioning system (GPS) solutions, founded in 2012 and based in San Francisco, California, with an additional location in Melbourne, Australia. The company develops hardware and software that provide centimeter-level accuracy through real-time kinematics (RTK) technology. Its product lineup includes the Piksi Multi GNSS Module, a versatile RTK receiver, and the Duro Ruggedized Receiver, designed for various industrial applications such as agriculture and robotics. Additionally, Swift Navigation offers the Skylark cloud corrections service and the Starling GNSS positioning engine, which caters to automotive and autonomous vehicle needs. The company's innovative solutions, characterized by their affordability and high accuracy—100 times better than standard GPS—serve multiple industries, including unmanned aerial vehicles, surveying, and space applications. Swift Navigation's commitment to making advanced positioning technology accessible is recognized by notable accolades, including mentions in Inc. and Forbes 30 Under 30 lists.
Inversago Pharma
Series C in 2022
Inversago Pharma Inc. is a preclinical-stage biotechnology company based in Montreal, Canada, focused on developing innovative therapies targeting metabolic and fibrotic disorders. The company specializes in peripherally-restricted CB1 receptor inverse agonists, which aim to offer new treatment options for conditions such as Prader-Willi syndrome, diabetes, and related metabolic disorders. Inversago Pharma's research includes addressing complications associated with diabetic kidney disease, non-alcoholic steatohepatitis, and various fibrotic diseases, including interstitial lung disease. Founded in 2015, the company is dedicated to enhancing patient outcomes through its pioneering approach to CB1 blockade.
Theorycraft Games
Series B in 2022
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki. Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.
Allakos
Post in 2022
Allakos Inc. is a clinical-stage biopharmaceutical company based in Redwood City, California, founded in 2012. The company focuses on developing antibody-based therapeutics aimed at treating various conditions linked to dysregulation of the T-helper type 2 immune response, such as allergic diseases and chronic inflammation. Its lead product, antolimab (AK002), targets conditions including eosinophilic gastritis, eosinophilic gastroenteritis, chronic urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Additionally, Allakos is developing AK006, an antibody that targets Siglec-6, an inhibitory receptor found on mast cells. By binding to Siglec-6, AK006 is designed to enhance the receptor's natural inhibitory function, thereby reducing mast cell activation and associated inflammatory responses.
Higlobe
Funding Round in 2022
Higlobe is an international payment platform established in 2020 and based in Palo Alto, California. It specializes in providing money transfer services for overseas freelancers, contractors, and independent workers who work with U.S. business clients. The platform offers a secure account supported by blockchain technology and features a team focused on anti-money laundering and fraud prevention. Higlobe distinguishes itself by eliminating international transaction fees, allowing non-U.S. freelancers and companies to withdraw payments from their U.S.-based clients quickly and without hidden costs.
Moximed
Series C in 2022
Moximed, Inc. is a medical technology company based in Hayward, California, focused on developing innovative solutions for patients with knee osteoarthritis. The company offers the Atlas System, an implantable joint unloader designed to alleviate pain for individuals suffering from medial compartment knee osteoarthritis. This system operates similarly to a shock absorber, providing dynamic load reduction to minimize joint pain and enhance mobility. Moximed also features the MISHA Knee System, which offers an outpatient treatment option for patients who have not found relief through other therapies and are not suitable candidates for knee replacement surgery. By addressing the specific needs of osteoarthritis patients, Moximed aims to improve their quality of life while potentially delaying the need for more invasive surgical interventions. Founded in 2006, the company serves patients and medical professionals worldwide.
ZeroFox
Post in 2022
ZeroFox, Inc. is a cybersecurity company that specializes in protecting organizations from social media-based threats and digital communication risks. Its cloud-based platform offers real-time threat analytics, intelligence, and comprehensive protection to identify, manage, and mitigate potential cyber threats. ZeroFox's solutions include monitoring for phishing attacks, account compromises, impersonation, and various forms of fraud, ensuring proactive defense through integration with existing security measures. The company also provides specialized services such as employee protection for high-value individuals and election protection for political campaigns and organizations. Established in 2013 and headquartered in Baltimore, Maryland, with additional offices in London, Las Condes, and Bengaluru, ZeroFox serves a diverse range of industries, including financial services, healthcare, technology, and media. By leveraging advanced technology and a global perspective on social media threats, ZeroFox aims to safeguard organizations against the evolving landscape of digital risks.
Everside Health
Venture Round in 2022
Everside Health is a direct primary care provider founded in 2010 and based in Denver, Colorado. The company offers a range of services, including biometric screenings, health risk assessments, lifestyle coaching, and acute care, catering to patients across the nation. Everside's healthcare delivery model is data-driven and patient-centric, focusing on convenient on-site, near-site, and virtual care options. By aligning incentives among patients, physicians, and benefit providers, Everside aims to enhance patient engagement and overall health while simultaneously reducing the total cost of care.
Gossamer Bio
Post in 2022
Gossamer Bio is a clinical-stage biopharmaceutical company based in San Diego that specializes in the discovery, development, and commercialization of innovative therapeutic products targeting significant unmet medical needs. Founded by former executives from Receptos, the company focuses on areas such as immunology, inflammation, fibrosis, and oncology. Its pipeline includes several promising candidates: Seralutinib, aimed at addressing pulmonary arterial hypertension; GB004, for inflammatory bowel disease; GB1275, targeting various oncology indications; and GB001, designed for moderate-to-severe eosinophilic asthma. Gossamer Bio's strategy involves leveraging a rich in-licensing environment to enhance its therapeutic offerings, supported by a team recognized for their successful track record in drug development.
QuoteWell
Series A in 2022
QuoteWell is a digital platform specifically designed for the insurance industry, founded in 2021 and headquartered in Austin, Texas. The company provides a data-driven solution that streamlines the submission process for insurance applications, allowing agents and brokers to efficiently transmit applications to various commercial lines underwriters. By facilitating secure data transfers to multiple carriers, QuoteWell enables users to access a modern risk transfer infrastructure and manage their book of business more effectively.
X4 Pharmaceuticals
Post in 2022
X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the discovery and development of innovative therapeutics for primary immune deficiencies and cancer. The company's lead drug candidate, mavorixafor, is an oral small molecule antagonist of the chemokine receptor CXCR4, currently undergoing multiple clinical trials. These include a Phase III trial for patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome, as well as Phase Ib and Phase IIa trials focused on severe congenital neutropenia and clear cell renal cell carcinoma, respectively. In addition, X4 Pharmaceuticals is advancing X4P-002, targeting glioblastoma multiforme, and X4P-003 aimed at primary immune deficiencies. The company has also established a license agreement with Abbisko Therapeutics to develop mavorixafor in combination with checkpoint inhibitors for oncology applications. Founded in 2014, X4 Pharmaceuticals was previously known as Arsanis, Inc. before rebranding in March 2019.
Narmi
Series B in 2022
Narmi Inc. is a technology company based in New York that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016, Narmi focuses on providing regional and community banks and credit unions with a platform that streamlines account opening processes, allowing clients to complete this in under 2.5 minutes. The company’s offerings include features such as fraud protection, multi-factor authentication, and transaction monitoring, which help enhance security and user experience. In addition to banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions. Their goal is to enable financial institutions to attract, engage, and retain customers through an intuitive, omnichannel banking experience.
Echodyne
Series D in 2022
Echodyne, established in 2014 and based in Kirkland, Washington, specializes in developing and marketing metamaterials-based radar systems. The company offers a range of radar solutions, including 3D Security radar for all-weather, compact, and solid-state sensor performance; Metamaterial Electronically Scanning Array (MESA) technology for high-performance phased-array radar at breakthrough cost levels; and Echoguard for ground-based airspace management. Additionally, Echodyne provides Acuity Software for customization and data processing, along with various deployment kits and accessories. Their products cater to commercial markets, government, defense, and industry, enabling autonomous applications in drones, vehicles, and heavy machinery, even in complex and challenging environments.
Lily AI
Venture Round in 2022
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.
Assembled
Series B in 2022
Assembled, Inc. operates a workforce management platform designed to enhance customer support operations for modern organizations. Founded in 2018 and based in San Francisco, California, the platform automates contact forecasting and staffing calculations while generating real-time productivity reports. It enables teams to efficiently forecast support volumes and create appropriate staffing plans, replacing the need for cumbersome spreadsheets and internal tools. Assembled features an intuitive team calendar that accommodates different time zones and specializations, allowing seamless integration with tools like Google Calendar and Slack for individual user interaction. Additionally, it provides visibility into support schedules and key metrics, such as response times, across all organizational levels. By facilitating the management of inbound support queries across multiple channels, including chat, email, phone, and social media, Assembled empowers organizations to optimize their customer support services.
Celcuity
Post in 2022
Celcuity Inc. is a clinical-stage biotechnology company based in Minneapolis, Minnesota, focused on advancing cancer treatment through innovative diagnostics. The company's CELsignia diagnostic platform utilizes living tumor cells to uncover specific cellular processes that drive cancer in individual patients. This approach enables the identification of new cancer sub-types that traditional molecular diagnostics may overlook, ultimately expanding therapeutic options. Celcuity is developing the CELsignia HSF test to diagnose two new sub-types of HER2-negative breast cancer and the CELsignia MP test for diagnosing 11 sub-types across various cancers, including breast, lung, colon, ovarian, kidney, and bladder. The company is also advancing its lead therapeutic candidate, gedatolisib, a pan-PI3K and mTOR inhibitor, currently being evaluated in a Phase 3 clinical trial for patients with advanced HR+/HER2- breast cancer.
Mashgin
Series B in 2022
Mashgin Inc. specializes in manufacturing intelligent kiosks that facilitate self-checkout at various retail environments, including cafés, convenience stores, and specialty shops. Founded in 2013 and based in Mountain View, California, the company utilizes advanced computer vision and deep learning technologies to streamline the checkout process. Its kiosks can recognize and process multiple items simultaneously, allowing customers to scan products based on their visual features such as color, shape, and size. This innovative system can be deployed quickly and at a lower cost compared to other self-checkout solutions. Currently, Mashgin's technology is in use at hundreds of locations, serving tens of thousands of customers daily.
Glacier
Seed Round in 2022
Glacier, founded in 2019 and based in San Francisco, California, has developed the first affordable, high-performing, and space-efficient AI-enabled robot designed specifically for recycling. The company aims to transform the recycling industry by utilizing artificial intelligence-powered sensors and robotics to automate the sorting of recyclable materials. This innovative approach allows recycling facilities to enhance their operational efficiency, improve sorting accuracy, and ultimately increase profitability. By integrating advanced technology into the recycling process, Glacier is positioned to significantly impact how recycling facilities manage and process materials.
Nodar
Series A in 2022
NODAR, Inc. is a Boston-based company that specializes in manufacturing advanced sensors for various transportation modes, including cars, trucks, drones, ships, trains, and aircraft. Established in 2018, NODAR focuses on developing cutting-edge camera-based 3D vision systems aimed at enhancing the safety and reliability of autonomous vehicles. Their flagship product, Hammerhead, utilizes off-the-shelf cameras to deliver long-range, ultra-precise depth sensing essential for Level 3 and Level 4 autonomous applications. This technology enables critical functionalities such as collision warning, path planning, and automatic emergency braking, while ensuring cost-effectiveness and high performance. NODAR's innovations target automotive, marine, and railway industries, providing solutions that meet the growing demand for reliable 3D sensing technology in the mainstream automotive market.
Genies
Series C in 2022
Genies, Inc. is a company specializing in avatar technology, enabling users to create personalized digital avatars for social media and messaging applications. By offering tools for designing avatars, avatar wearable fashion, and interactive experiences, Genies allows individuals to express their thoughts and feelings in a unique digital format. The company has gained significant traction among cultural influencers and has partnered with major music labels, serving as the official avatar provider for their artists. Genies has also launched consumer offerings, including an AR Developer Kit that facilitates the creation of interoperable avatar experiences in augmented reality. Their initial product, Silver Studio, allows users to design and trade digital fashion items. Founded in 2011 and headquartered in Venice, California, Genies has successfully raised substantial investment, positioning itself as a leader in the avatar space and driving engagement for brands through the sale of exclusive digital goods.
Built Robotics
Series C in 2022
Built Robotics Inc. is a technology company focused on automating the construction industry through the development of AI guidance systems that transform heavy equipment into autonomous robots. Founded in 2016 and headquartered in San Francisco, California, the company integrates various sensors, including GPS, cameras, and Lidar, with advanced software to enable earthmoving equipment to operate autonomously. Built Robotics aims to address the workforce gap in the construction sector, particularly in the $300 billion solar industry, by automating repetitive tasks and facilitating the construction of critical infrastructure such as wind farms, oil and gas pipelines, and new housing developments.
Trevi Therapeutics
Post in 2022
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an oral extended-release formulation. The company is focused on treating serious neurologically mediated conditions, specifically chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in individuals with Parkinson's disease. Trevi is currently conducting a Phase 2b/3 clinical trial, known as the PRISM trial, for nalbuphine ER, targeting severe pruritus associated with prurigo nodularis. The conditions being addressed share similar underlying mechanisms that involve opioid receptors in both the central and peripheral nervous systems. Founded in 2011, Trevi Therapeutics aims to provide innovative treatment options for patients suffering from these challenging health issues.
Antimatter
Series A in 2022
Antimatter is a company that provides cryptographic infrastructure services aimed at enhancing data security for B2B SaaS businesses. Founded in 2021 and located in Oakland, California, Antimatter's technology utilizes secure enclaves found in major cloud platforms to transparently encrypt customer data. This approach allows clients to adhere to stringent data security and privacy standards without necessitating any modifications to their existing code. By addressing the critical challenges of data security, Antimatter offers a solution that streamlines the protection of sensitive information for its customers.
SafeBase
Series A in 2022
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.
Alfred
Venture Round in 2022
Founded in 2014 by Marcela Sapone and Jessica Beck, Alfred is the largest and most advanced residential management platform. Since its inception, Alfred has focused on providing a resident-first experience. With an unparalleled knowledge of what residents want and technology that boosts income and efficiency for owners and operators, Alfred provides a single stop that elevates the rental ecosystem for all involved. Named by Fast Company as one of the Top 50 Most Innovative Companies, Alfred’s AOS technology drives lower operating costs and higher returns for property owners and operators. Through strategic partnerships with international real-estate owners and operators such as Hines, Related, RXR, Greystar, Invesco, Brookfield and J.P. Morgan, With RKW, Alfred’s portfolio now extends to more than 300,000 residents in 44 cities across the U.S. and Canada and has planned expansions in Europe, Israel and Asia.
Cohere Technologies
Series D in 2022
Cohere Technologies Inc. is a technology company specializing in wireless bandwidth applications, headquartered in Santa Clara, California. Founded in 2010, the company has developed a software solution that enhances the performance of mobile and wireless networks, specifically for 4G and 5G systems. Its innovative orthogonal time frequency and space (OTFS) modulation scheme addresses limitations in current technologies, such as TDMA and OFDM, to increase bandwidth and throughput. Additionally, Cohere Technologies is recognized as a pioneer in software-enhanced networks and is working towards solutions compliant with future 6G standards. Their offerings include spectrum multiplier software that improves channel detection, estimation, and precoding, thereby enhancing user experience and meeting the growing demand for wireless connectivity.
Beyond Identity
Series C in 2022
Beyond Identity, Inc. offers a cloud-native passwordless identity management platform that enhances secure authentication by replacing traditional passwords with X.509-based certificates. Founded in 2019 and based in New York, the company provides a comprehensive suite of features including frictionless login, biometric authentication, and Single Sign-On (SSO) integration for various users such as employees, contractors, and suppliers. Its innovative approach utilizes asymmetric-key cryptography to create a robust Chain of Trust, which incorporates user and device identities along with real-time security posture assessments for adaptive risk-based authentication. This technology not only improves security by eliminating credential-stuffing attacks but also facilitates increased business agility and efficiency, allowing organizations to adopt new business models and significantly reduce operational costs while achieving complete passwordless identity management.
Thunkable
Series B in 2022
Thunkable is a U.S.-based company that offers a platform for users to create mobile applications without extensive coding knowledge. Originating from MIT's App Inventor and participating in YCombinator's W2016 batch, Thunkable provides a free drag-and-drop interface that simplifies the app development process. Users can design applications using built-in templates and make real-time changes, which can be instantly previewed on their devices through the Thunkable mobile app. The platform supports automatic formatting for deployment across major operating systems, including Android and iOS, enabling individuals to build and publish native apps efficiently. By eliminating the need for large development tools or complex coding, Thunkable empowers users to create functional applications easily and share them directly with others or upload them to app stores.
HackerOne
Series E in 2022
HackerOne, established in 2012 and headquartered in San Francisco, operates a platform that connects businesses with cybersecurity researchers, known as "hackers". This platform facilitates ethical hacking, where these professionals identify vulnerabilities in companies' software applications. HackerOne mediates between the hackers and the businesses, enabling secure collaboration to improve security and protect consumer data. The company's services include bug bounty solutions, vulnerability disclosure programs, and coordination processes, helping organizations reduce security risks and build trust with their customers.
FTX US Derivatives
Series A in 2022
FTX US is a bitcoin options exchange designed to assist both individual traders and institutions in trading. FTX US allows users to trade a variety of digital assets like Bitcoin, Ethereum, Solana, and Dogecoin. The company was founded by Sam Bankman-Fried and Gary Wang in 2020 and is based in San Francisco, California.
Virtru
Series C in 2022
Virtru is a data security company based in Washington, D.C., founded in 2012. It offers a data protection platform that enables organizations to secure sensitive information while ensuring ease of use. The platform supports compliance with various regulations, including HIPAA, FERPA, CJIS, and ITAR, allowing businesses to maintain control over their data throughout its lifecycle—from creation and storage to sharing and analysis. Virtru is known for its development of the Trusted Data Format (TDF), an open industry standard for persistent data protection. More than 20,000 organizations across diverse sectors rely on Virtru's privacy technologies to safeguard their data.
Smartcar
Series B in 2022
Smartcar, Inc. is a technology company based in Mountain View, California, founded in 2014. It specializes in developing a platform that connects vehicles with mobility applications, enabling businesses to integrate their services with connected cars. Smartcar's API provides a range of functionalities, including access to vehicle data such as battery status, odometer readings, and location, as well as the ability to lock and unlock vehicles remotely. By offering a developer-friendly interface and comprehensive documentation, Smartcar facilitates the seamless integration of its services into various tech stacks, allowing clients to manage vehicle tracking, EV charging, and other automotive-related features efficiently.
Proof of Learn
Seed Round in 2022
Proof of Learn is a talent marketplace focused on educating and placing the next generation of developers. Founded in 2021 and based in Boston, the company operates Metacrafters.io, a multichain learn-to-earn platform that teaches users how to write smart contracts and build on-chain applications. The platform aims to provide equal access to education and job opportunities in the emerging Web3 space, utilizing blockchain technology to create a decentralized model for learning. By empowering learners to gain skills, earn rewards, and secure employment, Proof of Learn addresses the growing demand for qualified talent in the digital economy.
Aquabyte
Venture Round in 2022
Aquabyte, Inc. specializes in developing advanced monitoring systems for the fish farming industry, employing computer vision and machine learning technologies. Founded in 2017 and headquartered in San Francisco, California, with an office in Bergen, Norway, Aquabyte's smart camera system enables real-time applications such as detecting biomass, counting sea lice, and monitoring fish appetite. The accompanying web dashboard provides continuous metrics to enhance operational efficiency. By integrating these technologies, Aquabyte aims to reduce operational costs and fish mortality while promoting sustainability in aquaculture. The company’s innovative approach seeks to address the challenges faced by fish farms, ultimately contributing to a more efficient and environmentally friendly industry.
Korro Bio
Series B in 2022
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.
Mojo Vision
Series B in 2022
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Sorriso Pharmaceuticals
Series A in 2021
Sorriso Pharmaceuticals is a biotechnology company based in San Diego, California, founded in 2020. The company focuses on developing disease-modifying antibodies aimed at treating inflammatory diseases such as Crohn's disease and ulcerative colitis. Sorriso's innovative platform produces potent antibodies that can be delivered orally, ensuring they remain effective throughout the intestinal system. This approach aims to provide clinical benefits comparable to traditional injectable antibody therapeutics, thereby alleviating the treatment burden for patients who typically rely on injections for their care. By advancing its pipeline of oral therapies, Sorriso Pharmaceuticals seeks to improve patient outcomes and enhance the management of inflammatory diseases.
Pair Eyewear
Series B in 2021
Pair Eyewear, founded in 2017 and based in New York, specializes in customizable eyeglasses for children. The company offers a unique product line that includes base frames, which are standard glasses, and top frames, which are snap-on fronts that can be easily changed to reflect a child's evolving interests and personalities. By leveraging an e-commerce platform, Pair Eyewear aims to transform the eyeglass experience into an engaging activity for children while simplifying the process for parents. The brand focuses on quality and affordability, providing eyewear that combines style with functionality, featuring hand-polished acetate frames and shatterproof polycarbonate lenses.
Anyscale
Series C in 2021
Anyscale, Inc. is a technology company based in Berkeley, California, founded by the creators of the open-source project Ray. It specializes in developing distributed programming platforms and tools that simplify the creation and scaling of artificial intelligence applications. Anyscale's software enables developers and machine learning engineers to effortlessly scale their applications from local environments to the cloud, eliminating the need for complex infrastructure. The company's framework allows users of varying skill levels to build and deploy compute-intensive applications efficiently, facilitating faster and more cost-effective market entry for AI products. Anyscale aims to enhance the end-to-end AI lifecycle, making it accessible for organizations to leverage AI technologies.
Regulus Therapeutics
Post in 2021
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company based in San Diego, California, specializing in the discovery and development of therapies that target microRNAs for various diseases. The company is advancing its lead product candidates, RG-012 and RGLS4326, which are in Phase II and Phase Ib clinical trials, respectively. RG-012 targets miR-21 for the treatment of Alport syndrome, a severe kidney disease, while RGLS4326 targets miR-17 for autosomal dominant polycystic kidney disease. In addition to these candidates, Regulus is developing a pipeline of preclinical drug products, including RGLS5579, aimed at inhibiting miR-10b, as well as programs targeting hepatitis B virus and non-alcoholic steatohepatitis. Founded in 2007, Regulus Therapeutics is at the forefront of leveraging the therapeutic potential of microRNA, a significant scientific breakthrough in recent years.
Merge
Series A in 2021
Merge provides a comprehensive platform for B2B companies to streamline their integration processes through a single application programming interface (API). Founded in 2020, the company specializes in offering Unified APIs that facilitate secure data access across various software categories, such as human resources, accounting, customer relationship management, and file storage. Merge manages the complete integration lifecycle, from a swift initial setup to ongoing maintenance and observability tools, ensuring customer satisfaction. Its services help businesses enhance their operational efficiency by reducing customer churn, accelerating product development, and lowering engineering costs. Based in San Francisco, New York City, and Berlin, Merge has garnered significant support, receiving $75 million in funding from notable investors.
Contra
Series B in 2021
Contra is a professional networking platform based in San Francisco, California, founded in 2019 by Ben Huffman and Gajus Kuizinas. The platform is designed to empower users to work independently by providing access to flexible work opportunities through a community and referral network. By showcasing work portfolios, Contra enables freelancers and independent professionals to present their skills and attract potential clients, allowing them to earn a living on their own terms. The focus on independence and flexibility distinguishes Contra in the evolving landscape of professional networking.
Kiswe
Venture Round in 2021
Kiswe is a company that specializes in interactive video experiences, connecting at-home viewers with live events and in-venue fans. By leveraging cloud-based technology, Kiswe transforms the production and broadcasting of live games and events through its solution, Kiswe Studio. The platform is designed to create and manage direct-to-consumer streaming services, real-time live streams, and engaging digital experiences, thereby helping content owners, media companies, sports and eSports leagues, and music labels maximize their revenue and enhance fan engagement. Kiswe serves a diverse range of clients, including major broadcasters and entertainment entities. Headquartered in the United States, the company also has offices in Europe and Asia.
Attest
Series B in 2021
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.
Stride Health
Series C in 2021
Stride Health, Inc. operates a health benefits platform tailored for independent workers and part-time employees in the United States. The company provides a range of affordable health coverage options, including dental plans, doctor visits, and prescription insurance. By simplifying the enrollment process, Stride Health enables users to quickly select their most cost-effective health plans while also offering assistance from personal advisors to help navigate any complexities. Founded in 2013 and based in San Francisco, California, Stride Health was previously known as Covered, Inc. The company's mission is to make health insurance more accessible and manageable for those who may not have traditional employment benefits.
Slope.io
Series A in 2021
Slope.io, Inc. is a Mobile, Alabama-based company that specializes in clinical trial logistics, catering to sponsors, contract research organizations (CROs), and research sites throughout the United States. Founded in 2016, Slope.io provides a platform that streamlines the operational processes of clinical trials by translating logistical requirements into structured schedules and workflows. The company offers customized supply kits, known as Slope.io Kitting, tailored to specific sites, patients, or study time points. By connecting clinical trials to their supply chains, Slope.io effectively manages the complexity of delivering devices, drugs, and kits from suppliers to research sites and patients, ensuring real-time coordination and complete traceability.
Wizard
Series A in 2021
Wizard is a New York-based commerce technology startup founded in 2021 that focuses on transforming e-commerce through conversational artificial intelligence (AI). The company develops software solutions that enable brands to sell and market their products directly via text messaging. This innovative approach allows clients to engage customers more effectively, resulting in higher conversion rates compared to traditional e-commerce methods.
IonQ
Post in 2021
IonQ, Inc. is a technology company that specializes in the development of general-purpose quantum information computers utilizing a trapped ion approach. Founded in 2015 and based in College Park, Maryland, IonQ focuses on advancing quantum computing capabilities through qubit replication, optical networkability, and optimized algorithms. The company's quantum computers represent a significant shift from classical computing, effectively addressing limitations associated with superposition and entanglement at the atomic level. IonQ provides access to its quantum processors through cloud platforms, offering quantum-computing-as-a-service (QCaaS) to a wide range of customers. Additionally, the company engages in research and development to enhance its quantum technology and supports clients through consulting services aimed at co-developing algorithms for its quantum systems.
Pager
Series C in 2021
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Allay Therapeutics
Series C in 2021
Allay Therapeutics is focused on developing innovative pain management solutions aimed at improving post-surgical recovery for patients. The company utilizes a proprietary technology platform that integrates validated non-opioid analgesics with biopolymers to create dissolvable therapeutic products. These products are designed to deliver targeted pain relief at the surgical site over extended periods, significantly longer than conventional pain treatments. Allay's lead investigational product, ATX101, is currently undergoing evaluation in a Phase 2 clinical trial for total knee arthroplasty surgeries. With a team of experienced entrepreneurs, scientists, and clinicians based in the San Francisco Bay Area and Singapore, Allay Therapeutics is dedicated to transforming the approach to pain management and addressing the limitations associated with opioid use.
Rapid Robotics
Series B in 2021
Rapid Robotics, Inc. is a manufacturer of automated cell robots based in San Francisco, California, established in 2019. The company focuses on providing robotic solutions for manufacturers facing labor shortages and the complexities of material handling. Its AI-driven, vision-based platform is designed to handle a variety of palletizing tasks, allowing for rapid deployment of robotic workcells that can adapt to changing business needs. By offering a Robotics-as-a-Service (RaaS) model, Rapid Robotics enables companies to enhance their operational capacity and predictability without the financial burden and complexities associated with traditional robotic ownership and maintenance. The company's technology can be implemented quickly, often within hours, and at a significantly lower cost compared to other automation systems, ultimately improving production margins through increased efficiency and quality.
Airspan Networks
Post in 2021
Airspan Networks Inc. is a global provider of 4G broadband wireless systems and solutions, headquartered in Boca Raton, Florida. Founded in 1992, the company specializes in delivering high-speed data, voice, and multimedia services across various vertical markets, including smart utilities, transportation, and public safety. Airspan's product portfolio encompasses a range of technologies operating in licensed and unlicensed frequency bands from 700MHz to 6GHz. Their offerings include advanced small cells, pico base stations, and a virtual RAN platform, enabling seamless integration of LTE, WiMAX, Wi-Fi, and VoIP technologies. Airspan's solutions are designed to bridge connectivity gaps and enhance user experiences, with deployments in over 100 countries and a diverse customer base that includes Internet service providers and telecommunications carriers. The company also provides essential services such as network installation, integration, and support to facilitate the effective operation of its systems.
Tulip Interfaces
Series C in 2021
Tulip Interfaces, Inc. specializes in creating applications for the manufacturing industry that enhance shop floor operations. Founded in 2012 and based in Somerville, Massachusetts, the company offers a no-code platform that allows organizations to integrate data from various sources, including sensors and existing equipment. This integration facilitates the creation of digital work instructions and provides real-time visibility into operations, including the performance of personnel and machinery. Tulip serves a diverse range of industries, including consumer electronics, pharmaceuticals, apparel, and medical devices, helping companies improve productivity, quality, and operational efficiency. By leveraging advanced technologies such as intelligent hardware sensors, computer vision, and machine learning, Tulip's platform enables organizations to digitally transform their operations and achieve better end-to-end traceability.
Shape Therapeutics
Series B in 2021
Shape Therapeutics, Inc. is a biotechnology company founded in 2018 and based in Seattle, Washington. The company specializes in RNA-editing gene therapy targeting neurodegenerative disorders, oncology, metabolic conditions, and rare genetic diseases. Its proprietary RNAfix technology enables precise editing of RNA using the body's natural cellular mechanisms, which minimizes risks associated with immunogenicity, cellular toxicity, and off-target DNA editing. Shape Therapeutics employs a comprehensive approach to RNA gene therapy, integrating innovative payload, delivery, and manufacturing platform technologies. This strategy aims to facilitate the development of effective treatments and potential cures for a wide range of diseases, with the goal of enhancing patient outcomes across the healthcare landscape.
Vori Health
Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
AllyAlign Health
Venture Round in 2021
AllyAlign Health operates as a care management company dedicated to supporting patients with chronic and complex medical conditions. Founded in 2013 and based in Glen Allen, Virginia, the company offers an active care management platform that facilitates real-time, collaborative care across various boundaries. This platform connects patients with care teams, providers, and community-based services, ensuring access to essential health information, care plans, and benefits necessary for informed decision-making. Users can easily view, share, create, and update information according to their roles and responsibilities, with mobile and web-based options enhancing accessibility for patients and their families. A central, HIPAA-compliant database consolidates information from multiple sources, including electronic health records and lab tests, while semantic data modeling provides meaningful clinical insights.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.